Cargando…
TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome
Corticotroph macroadenomas are rare but difficult to manage intracranial neoplasms. Mutations in the two Cushing’s disease mutational hotspots USP8 and USP48 are less frequent in corticotroph macroadenomas and invasive tumors. There is evidence that TP53 mutations are not as rare as previously thoug...
Autores principales: | Perez-Rivas, Luis Gustavo, Simon, Julia, Albani, Adriana, Tang, Sicheng, Roeber, Sigrun, Assié, Guillaume, Deutschbein, Timo, Fassnacht, Martin, Gadelha, Monica R., Hermus, Ad R., Stalla, Günter K., Tichomirowa, Maria A., Rotermund, Roman, Flitsch, Jörg, Buchfelder, Michael, Nasi-Kordhishti, Isabella, Honegger, Jürgen, Thorsteinsdottir, Jun, Saeger, Wolfgang, Herms, Jochen, Reincke, Martin, Theodoropoulou, Marily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484083/ https://www.ncbi.nlm.nih.gov/pubmed/36123588 http://dx.doi.org/10.1186/s40478-022-01437-1 |
Ejemplares similares
-
Driver mutations in USP8 wild-type Cushing’s disease
por: Sbiera, Silviu, et al.
Publicado: (2019) -
Glucocorticoid Receptors Are Making a Comeback in Corticotroph Tumorigenesis
por: Theodoropoulou, Marily
Publicado: (2021) -
Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery—a retrospective, single-center study
por: Sumislawski, Piotr, et al.
Publicado: (2023) -
Genomics in Cushing’s Disease: The Dawn of a New Era
por: Reincke, Martin, et al.
Publicado: (2021) -
Genetics of Cushing’s disease: from the lab to clinical practice
por: Theodoropoulou, Marily, et al.
Publicado: (2022)